Dr. Lancaster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UPMC Cancer Centers
1030 beaner hollow rd
Beaver, PA 15009Phone+1 724-774-0778Fax+1 724-774-1109- Is this information wrong?
Education & Training
UMass Chan Medical SchoolResidency, Internal Medicine, 1982 - 1985
Pennsylvania State University College of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1987 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Publications & Presentations
PubMed
- 13 citationsPhase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal CancerBenedito A. Carneiro, Ramesh K. Ramanathan, Smitha S. Krishnamurthi, Barry C. Lembersky, Ronald G. Stoller, Stewart L. Lancaster, Theodore L. Crandall, Amy Schmotzer, ...> ;Clinical Colorectal Cancer. 2012 Mar 1
- Phase II study of biweekly cetuximab (C) and irinotecan (I) as a second-line regimen for metastatic colorectal cancer (mCRC).Carneiro BA, Bahary N, Lembersky B, Fakih M, Krishnamurthi SS, Lancaster S, Pinkerton R, Crandall T, Potter D, Ramanathan RK> ;J. Clin. Oncol.. 2009-05-20
Professional Memberships
- Member
Hospital Affiliations
UPMC PassavantPittsburgh, Pennsylvania- Shadyside CampusPittsburgh, Pennsylvania
- Heritage Valley Health SystemBeaver, Pennsylvania
UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
